美国FDA药品溶出方法数据库

药品通用名称	剂型	USP溶出装置	速度	溶出介质	介质体积	建议取样时间（分钟）	更新日期
Eszopiclone	Tablet			Refer to FDA's Dissolution Guidance, 2018			2020/07/02
Ethacrynic Acid	Tablet			Refer to USP			2010/12/23
Ethambutol HCl	Tablet			Develop a dissolution method			2024/01/03
Ethinyl Estradiol	Tablet			Refer to USP			2011/09/22
Ethinyl Estradiol/Ethynodiol Diacetate	Tablet			Develop a dissolution method			2023/09/15
Ethinyl Estradiol/Etonogestrel	Vaginal Ring			Develop a method to characterize in vitro release			2013/01/31
Ethinyl Estradiol/Levonorgestrel	Tablet			Develop a dissolution method			2024/01/03
Ethinyl Estradiol/Levonorgestrel	Transdermal System	V (paddle over disk)	75	0.25% Hydroxypropyl-Beta-Cyclodextrin (HPCD) in Water (Deaerated ), 32±0.5˚C	500	1, 2, 4, 6, 12, 24, 36, 48, 72 and 96 hours	2022/05/12
Ethinyl Estradiol/Norethindrone	Tablet (Chewable)	II (Paddle)	75	0.09% Sodium Lauryl Sulfate in 0.1 N HCl	500	10, 15, 20, 30 and 45	2008/01/14
Ethinyl Estradiol/Norethindrone	Tablet			Refer to USP			2009/07/15
Ethinyl Estradiol/Norethindrone Acetate	Tablet			Refer to USP			2009/07/15
Ethinyl Estradiol/Norethindrone Acetate	Capsule	II (Paddle)	100	Phosphate Buffer, pH 6.8, containing 0.07% w/v Triton X 100	900	5, 10, 20, 30, 45, 60 and 75	2018/02/15
Ethinyl Estradiol/Norethindrone Acetate [0.01mg,0.01 mg;1 mg]	Tablet (Chewable)	II (Paddle)	75	0.025 M Na Acetate Buffer with 0.15% Sodium Lauryl Sulfate [SLS] (pH 5.0) [degassed]	500	10, 15, 20, 30 and 45	2015/12/24
Ethinyl Estradiol/Norethindrone Acetate [0.02mg;1mg]	Tablet (Chewable)	II (Paddle)	75	0.025 M Sodium Acetate Buffer with 0.15% SLS, pH 5.0	600	10, 15, 20, 30 and 45	2014/02/14
Ethinyl Estradiol/Norgestimate	Tablet			Develop a dissolution method			2023/09/15
Ethinyl Estradiol/Norgestimate (AB)	Tablet			Develop a dissolution method			2023/09/15
Ethinyl Estradiol/Norgestrel	Tablet			Develop a dissolution method			2023/09/15
Ethinyl Estradiol; Norelgestromin	Film, Transdermal	Modified USP Type V (Paddle-over-disk)	50	0.1% Hydroxypropyl-beta-cyclodextrin at 32º C	900	0.25, 0.5, 1, 2, 4, 8, 12, 16, 20 and 24 hours	2009/05/20
Ethionamide	Tablet	I (Basket)	75	0.1 N HCl	900	10, 20, 30, 45 and 60	2013/01/31
Ethosuximide	Capsule			Refer to FDA's Dissolution Guidance, 2018			2020/07/02